BioLife Solutions, Inc.
BioLife Solutions, Inc. (BLFS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
blfs · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioLife Solutions, Inc. (BLFS) measures how much investors pay for each dollar of the company's trailing earnings. BLFS's current PE ratio of N/A is calculated by dividing its stock price of $26.64 by its TTM earnings per share of -$0.22.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioLife Solutions, Inc.You BLFS | $1.3B | N/A | — | -$0.22 |
 AtriCure, Inc. ATRC | $1.4B | N/A | — | -$0.24 |
 Azenta, Inc. AZTA | $1.1B | N/A | — | -$1.22 |
 Establishment Labs Holdings Inc. ESTA | $2.2B | N/A | — | -$1.72 |
 Harrow Health, Inc. HROW | $1.2B | N/A | — | -$0.14 |
 Kestra Medical Technologies, Ltd. KMTS | $1.2B | N/A | — | -$2.30 |
 Neogen Corporation NEOG | $2.0B | N/A | — | -$5.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.25 | — | |
2024-12-31 FY2024 | — | $-0.44 | — | |
2023-12-31 FY2023 | — | $-1.52 | — | |
2022-12-31 FY2022 | — | $-3.29 | — | |
2021-12-31 FY2021 | — | $-0.23 | — | |
2020-12-31 FY2020 | 408.42x | $0.10 | — | |
2019-12-31 FY2019 | — | $-0.09 | — | |
2018-12-31 FY2018 | 59.88x | $0.20 | — | |
2017-12-31 FY2017 | — | $-0.19 | — | |
2016-12-31 FY2016 | — | $-0.54 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioLife Solutions, Inc. (BLFS) measures how much investors pay for each dollar of the company's trailing earnings. BLFS's current PE ratio of N/A is calculated by dividing its stock price of $26.64 by its TTM earnings per share of -$0.22.
Frequently asked questions
BLFS pe ratio · 6 questionsBLFS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $26.64 and TTM EPS of -$0.22. Data sourced from Financial Modeling Prep via BLFS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioLife Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08